Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul;166(1):10-23.
doi: 10.1111/jnc.15652. Epub 2022 Jun 25.

Translational control by ketamine and its implications for comorbid cognitive deficits in depressive disorders

Vern Lewis  1 , Brandon Rodrigue  1 , Emily Arsenault  1 , Molly Zhang  1 , Fatimeh-Frouh Taghavi-Abkuh  1 , Weverton Castro Coelho Silva  1 , Mysa Myers  1 , Edna Matta-Camacho  1 , Argel Aguilar-Valles  1
Affiliations
Free article
Review

Translational control by ketamine and its implications for comorbid cognitive deficits in depressive disorders

Vern Lewis et al. J Neurochem. 2023 Jul.
Free article

Abstract

Ketamine has shown antidepressant effects in patients with major depressive disorder (MDD) resistant to first-line treatments and approved for use in this patient population. Ketamine induces several forms of synaptic plasticity, which are proposed to underlie its antidepressant effects. However, the molecular mechanism of action directly responsible for ketamine's antidepressant effects remains under active investigation. It was recently demonstrated that the effectors of the mammalian target of rapamycin complex 1 (mTORC1) signalling pathway, namely, eukaryotic initiation factor 4E (eIF4E) binding proteins 1 and 2 (4E-BP1 and 4E-BP2), are central in mediating ketamine-induced synaptic plasticity and behavioural antidepressant-like effect. 4E-BPs are a family of messenger ribonucleic acid (mRNA) translation repressors inactivated by mTORC1. We observed that their expression in inhibitory interneurons mediates ketamine's effects in the forced swim and novelty suppressed feeding tests and the long-lasting inhibition of GABAergic neurotransmission in the hippocampus. In addition, another effector pathway that regulates translation elongation downstream of mTORC1, the eukaryotic elongation factor 2 kinase (eEF2K), has been implicated in ketamine's behavioural effects. We will discuss how ketamine's rapid antidepressant effect depends on the activation of neuronal mRNA translation through 4E-BP1/2 and eEF2K. Furthermore, given that these pathways also regulate cognitive functions, we will discuss the evidence of ketamine's effect on cognitive function in MDD. Overall, the data accrued from pre-clinical research have implicated the mRNA translation pathways in treating mood symptoms of MDD. However, it is yet unclear whether the pro-cognitive potential of subanesthetic ketamine in rodents also engages these pathways and whether such an effect is consistently observed in the treatment-resistant MDD population.

Keywords: 4E-BPs; antidepressant; cognitive function; eEF2K; ketamine; mRNA translation; synaptic plasticity.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

REFERENCES

    1. Abdallah, C. G., Averill, L. A., Gueorguieva, R., Goktas, S., Purohit, P., Ranganathan, M., Sherif, M., Ahn, K. H., D’Souza, D. C., Formica, R., Southwick, S. M., Duman, R. S., Sanacora, G., & Krystal, J. H. (2020). Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin. Neuropsychopharmacology, 45, 990-997.
    1. Aguilar-Valles, A., De Gregorio, D., Matta-Camacho, E., Eslamizade, M. J., Khlaifia, A., Skaleka, A., Lopez-Canul, M., Torres-Berrio, A., Bermudez, S., Rurak, G. M., Simard, S., Salmaso, N., Gobbi, G., Lacaille, J.-C., & Sonenberg, N. (2021). Antidepressant actions of ketamine engage cell-specific translation via eIF4E. Nature, 590, 315-319.
    1. Aguilar-Valles, A., Haji, N., De Gregorio, D., Matta-Camacho, E., Eslamizade, M. J., Popic, J., Sharma, V., Cao, R., Rummel, C., Tanti, A., Wiebe, S., Nuñez, N., Comai, S., Nadon, R., Luheshi, G., Mechawar, N., Turecki, G., Lacaille, J.-C., Gobbi, G., & Sonenberg, N. (2018). Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E. Nature Communications, 9, 2459.
    1. Aguilar-Valles, A., Matta-Camacho, E., Khoutorsky, A., Gkogkas, C., Nader, K., Lacaille, J. C., & Sonenberg, N. (2015). Inhibition of group I metabotropic glutamate receptors reverses autistic-like phenotypes caused by deficiency of the translation repressor eIF4E binding protein 2. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 35, 11125-11132.
    1. Aguilar-Valles, A., Matta-Camacho, E., & Sonenberg, N. (2018). Translational control through the eIF4E binding proteins in the brain. In W. Sossin (Ed.), The Oxford handbook of neuronal protein synthesis. Oxford University Press.

MeSH terms

Substances

LinkOut - more resources